HIT Consultant Insightful coverage of healthcare innovation
> Cymfony > Pharmaceutical Social Media Marketing: Risks and Regulatory Issues
 

Pharmaceutical Social Media Marketing: Risks and Regulatory Issues

White Paper Published By: Cymfony
Cymfony
Published:  Sep 13, 2007
Type:  White Paper
Length:  27 pages

The pharmaceutical industry is very interested in using social media to promote products, services and issues important to it. However, many drug firm executives are uncertain about how to tackle the legal and regulatory issues associated with social media communications.



Tags : 
health, healthcare, pharmaceuticals, pharmaceutical, social media, fda, compliance, cymfony